Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea
· Delayed Price · Currency is KRW 1,493.00
-7.00 (-0.47%)
Feb 20, 2025, 9:00 AM KST
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 41.68 billion as of February 21, 2025. Its market cap has decreased by -65.57% in one year.
Market Cap
41.68B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
239.37
Stock Price
1,493.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 41.68B, a decrease of -90.40%. That is a compound annual growth rate of -39.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 41.68B | -53.34% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 384.51T |
| SK hynix | 144.35T |
| LG Energy Solution | 88.57T |
| Samsung Biologics | 82.35T |
| Hyundai Motor Company | 45.50T |
| Celltrion | 37.80T |
| Kia Corporation | 36.86T |
| NAVER | 34.26T |